InvestorsHub Logo
Followers 22
Posts 1086
Boards Moderated 0
Alias Born 10/26/2016

Re: None

Tuesday, 02/09/2021 11:17:11 PM

Tuesday, February 09, 2021 11:17:11 PM

Post# of 198829
CEO Charles Cotropia in the interview states “We do know that our identified initial target on the CoronaVirus is significantly different from the targets of the antibodies produced by Regeneron and Eli Lily. Thus, with a combination of our proposed broadly neutralizing anti-CoronaVirus antibodies, the administration of a “cocktail” of several antibodies could be expected to produce a more significant neutralizing effect.”

If a cocktail of several different monoclonal antibodies is expected to better neutralize Corona Virus, it would be advantageous for Eli Lily and Enzolytics to have a partnership. IMO it seems like CEO Cotropia almost tells you there is a partnership with Lily in this interview. $ENZC

https://www.ceocfointerviews.com/enzolytics20.html